Immune Checkpoint Inhibitors Related Cystoureteritis:
A Case Report and Literature Review / 中国肺癌杂志
Chinese Journal of Lung Cancer
; (12): 709-716, 2023.
Article
de Zh
| WPRIM
| ID: wpr-1010078
Bibliothèque responsable:
WPRO
ABSTRACT
A patient with advanced lung adenocarcinoma developed symptoms of frequent urination and urgent urination after 14 cycles of Pembrolizumab combined with chemotherapy. After making comprehensive analysis of the results of urine routine test, renal function, cystoscope and computed tomography (CT) examination, immune checkpoint inhibitors related cystoureteritis and acute kidney injury were considered. The patient's symptoms were relieved after discontinuation of Pembrolizumab combined with chemotherapy. However, the symptoms of urinary irritation worsened significantly after rechallenging Pembrolizumab combined with chemotherapy, and the symptoms was relieved after corticosteroids treatment. If patients develop urinary symptoms during immune checkpoint inhibitors treatment, immune checkpoint inhibitors related cystoureteritis should be considered for early differential diagnosis in order to implement appropriate treatment.
.
Mots clés
Texte intégral:
1
Base de données:
WPRIM
Sujet principal:
Tomodensitométrie
/
Adénocarcinome pulmonaire
/
Inhibiteurs de points de contrôle immunitaires
/
Tumeurs du poumon
Limites:
Humans
Langue:
Zh
Journal:
Chinese Journal of Lung Cancer
Année:
2023
Type de document:
Article